Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Current Deferred Revenue (2017 - 2021)

Historic Current Deferred Revenue for Catheter Precision (VTAK) over the last 5 years, with Q2 2021 value amounting to $1.8 million.

  • Catheter Precision's Current Deferred Revenue fell 387.31% to $1.8 million in Q2 2021 from the same period last year, while for Jun 2021 it was $1.8 million, marking a year-over-year decrease of 387.31%. This contributed to the annual value of $2.5 million for FY2020, which is 2321.34% up from last year.
  • According to the latest figures from Q2 2021, Catheter Precision's Current Deferred Revenue is $1.8 million, which was down 387.31% from $1.8 million recorded in Q1 2021.
  • Catheter Precision's 5-year Current Deferred Revenue high stood at $2.5 million for Q4 2020, and its period low was $1.7 million during Q4 2017.
  • Moreover, its 5-year median value for Current Deferred Revenue was $1.9 million (2020), whereas its average is $1.9 million.
  • Within the past 5 years, the most significant YoY rise in Catheter Precision's Current Deferred Revenue was 2321.34% (2020), while the steepest drop was 980.7% (2020).
  • Quarter analysis of 5 years shows Catheter Precision's Current Deferred Revenue stood at $1.7 million in 2017, then grew by 0.53% to $1.7 million in 2018, then grew by 17.76% to $2.0 million in 2019, then grew by 23.21% to $2.5 million in 2020, then dropped by 28.52% to $1.8 million in 2021.
  • Its Current Deferred Revenue was $1.8 million in Q2 2021, compared to $1.8 million in Q1 2021 and $2.5 million in Q4 2020.